Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


Celentis Acquires 100% Ownership Of Time Capsule

Celentis Acquires 100 Percent Ownership Of Time Capsule

HortResearch today announced the sale of its 50 percent stakeholding in the Time Capsule anti-facial eczema business to commercial science company Celentis who holds the other 50 percent of the business.

Chief Executive of HortResearch, Paul McGilvary said he was pleased to have negotiated the successful sale as the business although developed by HortResearch scientists fits better with the future focus of Celentis and AgResearch.

HortResearch would use the $3.25 million to $3.5 million for its 50 percent stake to further the progress of science within the company. This price includes the sale of the business and on going research and development contracts. $157,000 of the sale price will be shared among HortResearch staff involved with the development and manufacture and the Time Capsule.

"HortResearch looks forward to continuing to be involved with Celentis and the Time Capsule business as a provider of scientific and technological expertise, " Mr McGilvary said.

This sale, the first such deal between two Crown Research Institutes, has been endorsed by the Minister for CRI's Pete Hodgson. Mr Hodgson said he was delighted with the sale, and particularly pleased that HortResearch staff would be rewarded for creating and establishing the business.

Chief Executive of Celentis, Dr Stewart Washer said the full acquisition of Time Capsule was another step by Celentis to rapidly grow and add value to its technology subsidiaries.

"The Time Capsule product is an established technology for protecting sheep and cattle against facial eczema and generally enhancing livestock health. Purchasing the business outright was a strategic commercial move for us," he said.

Since its establishment, Celentis has made its mark in commercialising research and technology by matching market needs with scientific opportunity to develop leading edge customer solutions. In addition to its main areas of focus, Celentis owns stakes in subsidiary companies that are strategically aligned to the organisation's core businesses. These include AgVax Developments, BioProducts, Sastek, ComOne, Covita and Clone International.

Time Capsule uses a unique controlled-release technology to provide animals with a consistent daily dose of zinc which protects them from liver damage caused by the Sporidesmin toxin which, in turn, is produced by the fungus Pithomyces chartarum. It grows rapidly in pastures during warm, humid periods throughout January, February, March and April.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>


Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>


Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>


Half A Billion Accounts, Including Xtra: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>


Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news